AbstractObjective: Pulmonary transplantation has become the preferred treatment for end-stage lung disease, but application of the procedure is limited because of a paucity of donors. One way to solve donor limitations is to use animal organs as a donor source or xenotransplantation. The current barrier to pulmonary xenotransplantation is the rapid failure of the pulmonary xenograft. Although antibodies are known to play a role in heart and kidney xenograft rejection, their involvement in lung dysfunction is less defined. This project was designed to define the role of antibodies in pulmonary graft rejection in a pig-to-baboon model. Methods: Orthotopic transgenic swine left lung transplants were performed in baboons depleted of antibodies ...
Background. Previous studies demonstrated that hearts from transgenic pigs expressing human decayacc...
Background: Successful preclinical transplantations of porcine hearts into baboon recipients are req...
AbstractPulmonary transplantation is currently limited by the number of suitable cadaver donor lungs...
AbstractObjective: Pulmonary transplantation has become the preferred treatment for end-stage lung d...
AbstractThe use of nonhuman lung donors, such as swine, has the potential to provide an unlimited su...
AbstractBackground: A pig-to-goat orthotopic lung xenograft model was developed to test whether depl...
AbstractObjective: Our objectives were to study delayed xenograft rejection and the effectiveness of...
Delayed xenograft rejection (DXR) of pig organs by baboons currently represents the major obstacle t...
Background. Hyperacute rejection (HAR) is one of the principal obstacles to successful xenotransplan...
AbstractBackground:Human natural xenoantibodies represent a major hurdle to the clinical application...
Introduction After orthotopic cardiac xenotransplantation, the combination of both the inflammatory ...
Background: The demand for donated human hearts far exceeds the number available. Xenotransplantatio...
ObjectiveDuring ex vivo perfusion with human blood, homozygous galactosyl transferase knockout swine...
In the pig-to-baboon model, the removal of anti-porcine natural antibodies abrogates hyperacute vasc...
The use of animal organs for human transplantation could potentially alleviate the worldwide critica...
Background. Previous studies demonstrated that hearts from transgenic pigs expressing human decayacc...
Background: Successful preclinical transplantations of porcine hearts into baboon recipients are req...
AbstractPulmonary transplantation is currently limited by the number of suitable cadaver donor lungs...
AbstractObjective: Pulmonary transplantation has become the preferred treatment for end-stage lung d...
AbstractThe use of nonhuman lung donors, such as swine, has the potential to provide an unlimited su...
AbstractBackground: A pig-to-goat orthotopic lung xenograft model was developed to test whether depl...
AbstractObjective: Our objectives were to study delayed xenograft rejection and the effectiveness of...
Delayed xenograft rejection (DXR) of pig organs by baboons currently represents the major obstacle t...
Background. Hyperacute rejection (HAR) is one of the principal obstacles to successful xenotransplan...
AbstractBackground:Human natural xenoantibodies represent a major hurdle to the clinical application...
Introduction After orthotopic cardiac xenotransplantation, the combination of both the inflammatory ...
Background: The demand for donated human hearts far exceeds the number available. Xenotransplantatio...
ObjectiveDuring ex vivo perfusion with human blood, homozygous galactosyl transferase knockout swine...
In the pig-to-baboon model, the removal of anti-porcine natural antibodies abrogates hyperacute vasc...
The use of animal organs for human transplantation could potentially alleviate the worldwide critica...
Background. Previous studies demonstrated that hearts from transgenic pigs expressing human decayacc...
Background: Successful preclinical transplantations of porcine hearts into baboon recipients are req...
AbstractPulmonary transplantation is currently limited by the number of suitable cadaver donor lungs...